Byrne Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.2K | Sell |
|
|||||
|
2025
Q2 | $12.3K | Sell |
|
|||||
|
2025
Q1 | $13.4K | Sell |
|
|||||
|
2024
Q4 | $19.6K | Sell |
|
|||||
|
2024
Q3 | $35.5K | Sell |
|
|||||
|
2024
Q2 | $96.8K | Sell |
|
|||||
|
2024
Q1 | $145K | Buy |
|
|||||
|
2023
Q4 | $82.4K | Buy |
|
|||||
|
2023
Q3 | $67K | Sell |
|
|||||
|
2023
Q2 | $76K | Sell |
|
|||||
|
2023
Q1 | $75K | Sell |
|
|||||
|
2022
Q4 | $135K | Sell |
|
|||||
|
2022
Q3 | $162K | Sell |
|
|||||
|
2022
Q2 | $197K | Sell |
|
|||||
|
2022
Q1 | $316K | Sell |
|
|||||
|
2021
Q4 | $458K | Buy |
|